Search Results 1041-1050 of 18065 for Pathogens

  1. Crohn's disease - Doctors and departments - Mayo Clinic

    Learn about symptoms and treatment for this debilitating, but treatable, digestive condition.

  2. Laboratories - Mayo Clinic Research

    K. Kidney Disease Discovery: Peter C. Harris · Knowledge and Evaluation Research Unit · Knowledge Inference in Medical Image Analysis: Hamid R. Tizhoosh ...

  3. Encaleret Compared to Standard of Care in Participants with Autosomal Dominant Hypocalcemia Type 1 - Mayo Clinic

    Participants must have a documented pathogenic activating variant, or variant of uncertain significance, of the CASR gene associated with biochemical ...

  4. Hepatitis B - Doctors and departments - Mayo Clinic

    This contagious liver infection can be long lasting. Learn how the infection spreads and what you can do to prevent or treat it.

  5. Crohn's disease - Doctors and departments - Mayo Clinic

    Departments that treat this condition · Colon and Rectal Surgery · Gastroenterology and Hepatology · Inflammatory Bowel Disease Clinic · Laboratory Medicine and ...

  6. Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery - Mayo Clinic

    Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Ibrutinib may stop the growth of tumor cells by ...

  7. Crohn's disease - Doctors and departments - Mayo Clinic

    Learn about symptoms and treatment for this debilitating, but treatable, digestive condition.

  8. MAYO CLINIC HEPATOBILIARY SPORE RENEWED

    Mayo Clinic is again top-ranked in more specialties than any other hospital and has two hospitals recognized as Honor Roll members — the highest honor — in ...

  9. A Registry for Participants with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection - Mayo Clinic

    About this study. This Registry will enroll cirrhotic participants with or without decompensated liver disease who have achieved a sustained virologic ...

  10. Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 - Mayo Clinic

    Participation eligibility · Documentation of PH1 as determined by genetic analysis confirming pathogenic mutations in the alanine-glyoxylate aminotransferase ( ...